‘First’ Therapeutic Approvals Bring Patients Hope
When novel drugs and biologics hit the market, the treatment horizon for many patients is suddenly broadened. US Food and…
When novel drugs and biologics hit the market, the treatment horizon for many patients is suddenly broadened. US Food and…
The current COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, is the current focus of numerous drug therapies and vaccine…
At the peak of the COVID-19 pandemic, clinical study monitors and patients were restricted from sites. Sponsors and CROs had…
Within this evolving world of biopharma, it is estimated that two-thirds of biopharmaceutical manufacturing is outsourced. Therefore, the supplychain is…
The pressures on pharmaceutical organisations to capture, sift and process real-world adverse event data are immense – and soaring. So…
Contact-tracing apps and technologies are a hotly debated issue with legal, medical and technological implications. The most common mistake in…
The outbreak of COVID-19 created unprecedented circumstances for the conduct of clinical trials across the world. While the industry has…
Clinical research is a complex, expensive, and time- and resourceintensive process. Feasibility assessments play a crucial part in this clinical…
The medical device industry makes a colossal number of items ranging from invasive gloves to non-natural joints to imaging gear…
The low representation of African countries in clinical trials is not unusual. Poor visibility of existing sites, limited infrastructure, cultural…